Justifying health insurance expenditure
It can be difficult for public health insurers to decide which medical interventions to cover. After all, it is the […]
Gender transition is in transition
Transgender health management has seen important advances in the recent past. Some notable remaining issues revolve around the standard of […]
Organ donation part 3/4 – The futures that never happened
Futures contracts for donations after death appear to ease major ethical concerns in the debate about payment for human organs. […]
Organ donation part 2/4 – Which incentives are there?
It has been argued for decades that meaningful incentives are needed for substantially more individuals to donate organs. Existing and […]
The future(s) of healthcare?
Planning and financing healthcare is a challenging task for individuals, private insurance providers and governments. Public and private insurances must […]
Aberdeen Donside Hydro
I finally took the time for a wee excursion down the river Don to have a look at the new […]
iCancer – The first step into the future of funding clinical trials?
After I tweeted about my recent post about Immunium, another Twitter user made me aware of iCancer. Why? – Because […]
Immunicum – Scalable Personalised Cancer Immunotherapy
I thought I kick off the year with an article about Immunicum, a Swedish company I stumbled across a week […]